[1]
M. Romaniuk and P. Aksonov, “Dutasteride 5α-reductase Inhibitor in the Treatment of Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis”, HM, no. 1, pp. 85–90, Jun. 2021.